IKImamuddin Khan

Imamuddin Khan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Imamuddin Khan has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Anju Dhawan

    Department of Psychiatry, National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences, New Delhi, Delhi, India

    2 shared publications
  • Omar Afroz

    Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, Delhi, India

    1 shared publication
  • Omar Afroz

    All India Institute of Medical Sciences (AIIMS)

    1 shared publication
  • Sonali Jhanjee

    Department of Psychiatry, National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences, New Delhi, Delhi, India

    1 shared publication
  • Sonali Jhanjee

    National Drug Dependence Treatment Centre, All India Institute Of Medical Sciences, New Delhi, India

    1 shared publication

Latest Publications

  • Circumstances of first injection and factors driving or deterring injection initiation among males with opioid use disorder

    by Imamuddin Khan, Sonali Jhanjee, Anju Dhawan, Omar Afroz

    Background: Opioid use through injection drug use is associated with a significant global health burden. In most patients, injection drug use is initiated after a transition period of 1–5 years. Aim: To assess the circumstances involving the first injection of drugs and the reasons for transitioning to injection drug use among injection drug users with opioid use disorder. Materials and Methods: One hundred males seeking treatment for opioid use disorders at a tertiary care drug dependence treatment center in North India were recruited through purposive sampling, comprising 50 injection drug users (IDU) and 50 noninjecting opioid users (NIOU). A semistructured proforma was used to obtain information about the circumstances of first injection and reasons for transition to injection drug use among IDU ( n = 50). Reasons preventing this transition among the NIOUs ( n = 50) were also assessed. Results: Mean duration of transition was 4.4 years. For the majority of participants, the first injection was spontaneous (64%) and involved suggestion (74%) and administration (90%) by someone else. Heroin was the most common drug (58%), and public places were the most common locations (28%). Peer/partner influence was the most common reason for transition (66%), followed by easy availability (60%) and environmental influence (44%). Among NIOU, fear of health consequences (86%), fear of blood/needle (58%), and environmental influence (20%) were the most common reasons deterring transition. Conclusions: This cross-sectional study found that the initiation of injection drug use is often a nonspontaneous event, with the idea coming from someone else.

  • Open Access

    A Comparative Study of Sociodemographic, Clinical, and Psychosocial Parameters Between Injecting and Non-injecting Opioid-dependent Males

    by Imamuddin Khan, Sonali Jhanjee, Anju Dhawan, Omar Afroz

    Background: Opioid use disorder (OUD), particularly injection drug use (IDU), is on the rise and is associated with complications such as blood-borne infections, overdosing, and seizures, among others. Understanding factors distinguishing non-injecting opioid users (NIOU) and IDUs is essential for the development of effective prevention and management strategies. This study aimed to compare sociodemographic, clinical, and psychosocial factors between IDUs and NIOUs. Methods: A cross-sectional study was conducted at a tertiary care center in North India, including 100 opioid-dependent males (50 NIOUs and 50 IDUs). Sociodemographic, clinical, and psychosocial variables were assessed using structured interviews and validated instruments, including the Maudsley Addiction Profile, the severity of dependence scale (SDS), the high-risk behavior scale (HRBS), the sensation seeking scale (SSS), the Barratt Impulsiveness Scale (BIS), and the WHO-ASSIST. Results: IDUs had significantly higher histories of alcohol use, duration of cannabis use, and family history of substance use, and significantly higher scores on HRBS, BIS, and the SSS ( p < .05). WHO-ASSIST and SDS scores were comparable between the groups. IDUs had a substantially higher number of days of heroin use in the last month and days of conflicts with relatives ( p < .05). Mean duration of the transition period from NIOU to IDU was 4 ± 3.3 years. Conclusions: Family history of drug use, higher sensation seeking, impulsivity, and risk-taking behavior were found to be important factors related to IDU. Interventions targeting these factors are essential for preventing the transition from NIOU to IDU.